DEA schedule
Is mycophenolate a controlled substance?
Federal schedule for mycophenolate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Mycophenolate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and mycophenolate is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted mycophenolate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 35 prescription listings from 16 labelers, none with a DEA schedule |
| DEA controlled substances list | mycophenolate is not on the list |
Mycophenolate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0078-0385 | Myfortic | tablet, delayed release | 180 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0078-0386 | Myfortic | tablet, delayed release | 360 mg/1 | Novartis Pharmaceuticals Corporation | None |
| 0904-6785 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | Major Pharmaceuticals | None |
| 16729-261 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | Accord Healthcare Inc. | None |
| 59651-621 | MYCOPHENOLIC ACID | tablet, delayed release | 180 mg/1 | Aurobindo Pharma Limited | None |
| 60429-016 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | Golden State Medical Supply, Inc. | None |
| 60505-2965 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | Apotex Corp | None |
| 67877-426 | MYCOPHENOLIC ACID | tablet, delayed release | 180 mg/1 | Ascend Laboratories, LLC | None |
| 67877-928 | MYCOPHENOLIC ACID | tablet, delayed release | 180 mg/1 | Ascend Laboratories, LLC | None |
| 68084-907 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | American Health Packaging | None |
| 68254-5001 | mycophenolic acid | tablet, delayed release | 180 mg/1 | CONCORD BIOTECH LIMITED | None |
| 70377-039 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | Biocon Pharma Inc. | None |
| 70377-126 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | Biocon Pharma Inc. | None |
| 70436-172 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | Slate Run Pharmaceuticals, LLC | None |
| 72888-199 | mycophenolic acid | tablet, delayed release | 180 mg/1 | Advagen Pharma Limited | None |
| 82293-012 | Mycophenolic Acid | tablet, delayed release | 180 mg/1 | Novugen Pharma (USA) LLC. | None |
| 85972-161 | mycophenolic acid | tablet, delayed release | 180 mg/1 | Stellon Biotech Inc. | None |
| 0904-6786 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | Major Pharmaceuticals | None |
| 0904-7372 | MYCOPHENOLIC ACID | tablet, delayed release | 360 mg/1 | Major Pharmaceuticals | None |
| 16729-189 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | Accord Healthcare Inc. | None |
| 50090-6492 | MYCOPHENOLIC ACID | tablet, delayed release | 360 mg/1 | A-S Medication Solutions | None |
| 59651-622 | MYCOPHENOLIC ACID | tablet, delayed release | 360 mg/1 | Aurobindo Pharma Limited | None |
| 60429-017 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | Golden State Medical Supply, Inc. | None |
| 60505-2966 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | Apotex Corp | None |
| 67877-427 | MYCOPHENOLIC ACID | tablet, delayed release | 360 mg/1 | Ascend Laboratories, LLC | None |
| 67877-929 | MYCOPHENOLIC ACID | tablet, delayed release | 360 mg/1 | Ascend Laboratories, LLC | None |
| 68084-918 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | American Health Packaging | None |
| 68254-5002 | mycophenolic acid | tablet, delayed release | 360 mg/1 | CONCORD BIOTECH LIMITED | None |
| 70377-040 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | Biocon Pharma Inc. | None |
| 70377-127 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | Biocon Pharma Inc. | None |
| 70436-173 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | Slate Run Pharmaceuticals, LLC | None |
| 70518-4391 | MYCOPHENOLIC ACID | tablet, delayed release | 360 mg/1 | REMEDYREPACK INC. | None |
| 72888-200 | mycophenolic acid | tablet, delayed release | 360 mg/1 | Advagen Pharma Limited | None |
| 82293-013 | Mycophenolic Acid | tablet, delayed release | 360 mg/1 | Novugen Pharma (USA) LLC. | None |
| 85972-162 | mycophenolic acid | tablet, delayed release | 360 mg/1 | Stellon Biotech Inc. | None |
Questions
Is mycophenolate a controlled substance?
No. Mycophenolate is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and mycophenolate is not on the DEA controlled substances list.
Is mycophenolate a narcotic?
No. Mycophenolate is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Antimetabolite Immunosuppressant.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.